The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Ligand modified nanoparticles increases cell uptake, alters endocytosis and elevates glioma distribution and internalization
Open accessAbstract
Nanoparticles (NPs) were widely used in drugs/probes delivery for improved disease diagnosis and/or treatment. Targeted delivery to cancer cells is a highly attractive application of NPs. However, few studies have been performed on the targeting mechanisms of these ligand-modified delivery systems. Additional studies are needed to understand the transport of nanoparticles in the cancer site, the interactions between nanoparticles and cancer cells, the intracellular trafficking of nanoparticles within the cancer cells and the subcellular destiny and potential toxicity. Interleukin 13 (IL-13) peptide can specifically bind IL-13Rα2, a receptor that is highly expressed on glioma cells but is expressed at low levels on other normal cells. It was shown that the nanoparticels modification with the IL-13 peptide could improve glioma treatment by selectively increasing cellular uptake, facilitating cell internalization, altering the uptake pathway and increasing glioma localization.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Understanding biophysicochemical interactions at the nano–bio interface
Nel, A. E., Mädler, L., Velegol, D., Xia, T., Hoek, E. M. V., Somasundaran, P., Klaessig, F., Castranova, V., & Thompson, M. (2009) · Nature Materials · doi:10.1038/nmat2442 · Cited by 7,083
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Targeted drug delivery to tumors: Myths, reality and possibility
Bae, Y. H., & Park, K. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.06.001 · Cited by 1,935
Kirpotin, D. B., Drummond, D. C., Shao, Y., Shalaby, M. R., Hong, K., Nielsen, U. B., Marks, J. D., Benz, C. C., & Park, J. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4199 · Cited by 1,125
Ashley, C. E., Carnes, E. C., Phillips, G. K., Padilla, D., Durfee, P. N., Brown, P. A., Hanna, T. N., Liu, J., Phillips, B., Carter, M. B., et al. (2011) · Nature Materials · doi:10.1038/nmat2992 · Cited by 1,024
Self-citationDelivery of molecular and cellular medicine to solid tumors
Jain, R. K. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.011 · Cited by 774
Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles
Choi, C. H. J., Alabi, C. A., Webster, P., & Davis, M. E. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914140107 · Cited by 699
Aptamer-functionalized PEG–PLGA nanoparticles for enhanced anti-glioma drug delivery
Guo, J., Gao, X., Su, L., Xia, H., Gu, G., Pang, Z., Jiang, X., Yao, L., Chen, J., & Chen, H. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.07.004 · Cited by 566
Self-citationNam, H. Y., Kwon, S. M., Chung, H., Lee, S.-Y., Kwon, S.-H., Jeon, H., Kim, Y., Park, J. H., Kim, J., Her, S., et al. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.01.018 · Cited by 564
Jain, R. K. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00131-9 · Cited by 529
Wang, Y., Wang, K., Zhao, J., Liu, X., Bu, J., Yan, X., & Huang, R. (2013) · Journal of the American Chemical Society · doi:10.1021/ja312221g · Cited by 527
Self-Assembled Targeted Nanoparticles: Evolution of Technologies and Bench to Bedside Translation
Shi, J., Xiao, Z., Kamaly, N., & Farokhzad, O. C. (2011) · Accounts of Chemical Research · doi:10.1021/ar200054n · Cited by 476
Ren, J., Shen, S., Wang, D., Xi, Z., Guo, L., Pang, Z., Qian, Y., Sun, X., & Jiang, X. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.01.025 · Cited by 408
Self-citationAnalysis of clathrin-mediated endocytosis of epidermal growth factor receptor by RNA interference
Huang, F., Khvorova, A., Marshall, W., & Sorkin, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400046200 · Cited by 402
Xin, H., Jiang, X., Gu, J., Sha, X., Chen, L., Law, K., Chen, Y., Wang, X., Jiang, Y., & Fang, X. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.02.044 · Cited by 384
Self-citationZhan, C., Gu, B., Xie, C., Li, J., Liu, Y., & Lu, W. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.12.020 · Cited by 366
Effect of Nanoparticles on the Cell Life Cycle
Mahmoudi, M., Azadmanesh, K., Shokrgozar, M. A., Journeay, W. S., & Laurent, S. (2011) · Chemical Reviews · doi:10.1021/cr1003166 · Cited by 352
Does a targeting ligand influence nanoparticle tumor localization or uptake?
Pirollo, K. F., & Chang, E. H. (2008) · Trends in Biotechnology · doi:10.1016/j.tibtech.2008.06.007 · Cited by 347
Xin, H., Sha, X., Jiang, X., Zhang, W., Chen, L., & Fang, X. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.07.046 · Cited by 311
Self-citationDelivery of molecularly targeted therapy to malignant glioma, a disease of the whole brain
Agarwal, S., Sane, R., Oberoi, R., Ohlfest, J. R., & Elmquist, W. F. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399411001888 · Cited by 292
Precise glioma targeting of and penetration by aptamer and peptide dual-functioned nanoparticles
Gao, H., Qian, J., Cao, S., Yang, Z., Pang, Z., Pan, S., Fan, L., Xi, Z., Jiang, X., & Zhang, Q. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.03.058 · Cited by 280
Self-citationPreparation and brain delivery property of biodegradable polymersomes conjugated with ox26
Pang, Z., Lu, W., Gao, H., Hu, K., Chen, J., Zhang, C., Gao, X., Jiang, X., & Zhu, C. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.03.007 · Cited by 264
Self-citationLu, W., Sun, Q., Wan, J., She, Z., & Jiang, X.-G. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2354 · Cited by 219
Self-citationKibria, G., Hatakeyama, H., Ohga, N., Hida, K., & Harashima, H. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.03.012 · Cited by 200
Yan, H., Wang, L., Wang, J., Weng, X., Lei, H., Wang, X., Jiang, L., Zhu, J., Lu, W., Wei, X., et al. (2012) · ACS Nano · doi:10.1021/nn203749v · Cited by 191
Gu, G., Xia, H., Hu, Q., Liu, Z., Jiang, M., Kang, T., Miao, D., Tu, Y., Pang, Z., Song, Q., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2012.09.044 · Cited by 184
Self-citation“Targeting” nanoparticles: The constraints of physical laws and physical barriers
Florence, A. T. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.022 · Cited by 179
Recent advances in brain tumor-targeted nano-drug delivery systems
Liu, Y., & Lu, W. (2012) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2012.682726 · Cited by 161
Pang, Z., Feng, L., Hua, R., Chen, J., Gao, H., Pan, S., Jiang, X., & Zhang, P. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100277h · Cited by 156
Self-citationSun, X., Pang, Z., Ye, H., Qiu, B., Guo, L., Li, J., Ren, J., Qian, Y. J., Zhang, Q., Chen, J., et al. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.10.035 · Cited by 139
Self-citationMickler, F. M., Möckl, L., Ruthardt, N., Ogris, M., Wagner, E., & Bräuchle, C. (2012) · Nano Letters · doi:10.1021/nl300395q · Cited by 131
Regulation of Endocytic Clathrin Dynamics by Cargo Ubiquitination
Henry, A. G., Hislop, J. N., Grove, J., Thorn, K. S., Marsh, M., & von Zastrow, M. (2012) · Developmental Cell · doi:10.1016/j.devcel.2012.08.003 · Cited by 107
Qian, Y. J., Zha, Y., Feng, B. C., Pang, Z., Zhang, B., Sun, X., Ren, J., Zhang, C., Shao, X., Zhang, Q., et al. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.11.050 · Cited by 99
Self-citationRaoof, M., Mackeyev, Y., Cheney, M. A., Wilson, L. J., & Curley, S. A. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.12.043 · Cited by 96
Fillmore, H. L., Shultz, M. D., Henderson, S. C., Cooper, P. S., Broaddus, W. C., Chen, Z. J., Shu, C., Zhang, J., Ge, J., Dorn, H. C., et al. (2011) · Nanomedicine · doi:10.2217/nnm.10.134 · Cited by 90
Pang, Z., Gao, H., Yu, Y., Chen, J., Guo, L., Ren, J., Wen, Z., Su, J., & Jiang, X. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.05.063 · Cited by 82
Self-citationBertelsen, V., Sak, M. M., Breen, K., Rødland, M. S., Johannessen, L. E., Traub, L. M., Stang, E., & Madshus, I. H. (2011) · Traffic · doi:10.1111/j.1600-0854.2011.01162.x · Cited by 48
Jones‐Bolin, S., Zhao, H. Q., Hunter, K., Klein–Szanto, A. J., & Ruggeri, B. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0327 · Cited by 42
Capacity of the Golgi Apparatus for Cargo Transport Prior to Complete Assembly
Jiang, S., Rhee, S. W., Gleeson, P. A., & Storrie, B. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-12-1112 · Cited by 40
Preubiquitinated chimeric ErbB2 is constitutively endocytosed and subsequently degraded in lysosomes
Vuong, T. T., Berger, C., Bertelsen, V., Rødland, M. S., Stang, E., & Madshus, I. H. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.10.010 · Cited by 15
Cited by
Nanoparticle-Based Immunotherapy for Cancer
Shao, K., Singha, S., Clemente-Casares, X., Tsai, S., Yang, Y., & Santamaria, P. (2015) · ACS Nano · doi:10.1021/nn5062029 · Cited by 470
Drug Delivery via Cell Membrane Fusion Using Lipopeptide Modified Liposomes
Yang, J., Bahreman, A., Daudey, G., Bussmann, J., Olsthoorn, R. C. L., & Kros, A. (2016) · ACS Central Science · doi:10.1021/acscentsci.6b00172 · Cited by 299
Application of Nanotechnology in Drug Delivery
(2014) · InTech eBooks · doi:10.5772/57028 · Cited by 266
Graham, U. M., Tseng, M. T., Jasinski, J. B., Yokel, R. A., Unrine, J. M., Davis, B. H., Dozier, A. K., Hardas, S. S., Sultana, R., Grulke, E. A., et al. (2014) · ChemPlusChem · doi:10.1002/cplu.201402080 · Cited by 72
Zhang, Q., Rajan, S. S., Tyner, K. M., Casey, B. J., Dugard, C. K., Jones, Y., Paredes, A. M., Clingman, C. S., Howard, P. C., & Goering, P. L. (2016) · Journal of Biomedical Materials Research Part B: Applied Biomaterials · doi:10.1002/jbm.b.33450 · Cited by 15
Metadata
- Authors
- Gao, H., Yang, Z., Zhang, S., Cao, S., Shen, S., Pang, Z., & Jiang, X.
- Venue
- Scientific Reports
- Published
- 2013-08-28
- Volume
- 3
- Issue
- 1
- Pages
- 2534-2534
- ISSN
- 2045-2322 (ISSN-L)
- OpenAlex
- W1964429118
- Cited by
- 306
- References
- 40
- FWCI
- 13.06
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
